<DOC>
	<DOC>NCT00315640</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.</brief_summary>
	<brief_title>Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Either gender 18 years of age or older IOP elevation caused by steroid usage Other protocoldefined inclusion criteria may apply Under 18 years of age Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Elevated IOP due to intravitreal triamcinolone therapy</keyword>
</DOC>